Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 661–675 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4156 SLC1A4 Gene Genetic Test for Developmental Delay & Microcephaly This test evaluates the SLC1A4 gene for pathogenic variants associated with developmental delay and progressive microcephaly.	Whole Blood (EDTA) – 2 mL	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC1A4 gene", "Copy Number Variations (CNV) in the SLC1A4 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected SLC1A4-related disorder", "Developmental delay with microcephaly"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q02 Clinical summary This test evaluates the SLC1A4 gene for pathogenic variants associated with developmental delay and progressive microcephaly.
TEST-3072 SLC20A2 Gene Idiopathic Basal Ganglia Calcification Type 1 Test This diagnostic test evaluates the SLC20A2 gene for pathogenic variants associated with idiopathic basal ganglia calcification type 1 (Fahr's disease).	Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC20A2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with progressive neurological symptoms", "Bilateral basal ganglia calcifications on neuroimaging", "Family history of Fahr's disease"] Measurement technique Confirm with laboratory Codes LOINC: 101376-5 ICD-10: G23.8 Clinical summary This diagnostic test evaluates the SLC20A2 gene for pathogenic variants associated with idiopathic basal ganglia calcification type 1 (Fahr's disease).
TEST-6154 SLC22A12 Gene Hypouricemia, Renal Type 1 Genetic Test This genetic test evaluates the SLC22A12 gene for mutations causing hereditary renal hypouricemia type 1.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the SLC22A12 gene"] Parameters [] Preparation ["No specific contraindications for sample collection", "Genetic counselling session must be completed"] Indications ["Individuals with persistently low serum uric acid ( Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E79.8 Clinical summary This genetic test evaluates the SLC22A12 gene for mutations causing hereditary renal hypouricemia type 1.
TEST-5913 SLC25A19 Gene (Thiamine Metabolism Dysfunction Syndrome 4, Progressive Polyneuropathy Type) Genetic Test This genetic test evaluates the SLC25A19 gene for pathogenic variants associated with Thiamine Metabolism Dysfunction Syndrome 4 (progressive polyneuropathy type).	Whole blood (EDTA) or Dried Blood Spot (FTA card)	3–4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC25A19 gene", "Thiamine metabolism dysfunction"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "A three-generation pedigree chart is required"] Indications ["Suspected hereditary peripheral neuropathy", "Clinical and neurophysiological findings suggesting a hereditary metabolic neuropathy", "Carrier screening in families with a known mutation"] Measurement technique Confirm with laboratory Codes LOINC: 94455-4 ICD-10: E88.89 Clinical summary This genetic test evaluates the SLC25A19 gene for pathogenic variants associated with Thiamine Metabolism Dysfunction Syndrome 4 (progressive polyneuropathy type).
TEST-6238 SLC26A3 Gene Congenital Secretory Chloride Diarrhea Type 1 Genetic Test This diagnostic test evaluates the SLC26A3 gene for pathogenic mutations associated with congenital secretory chloride diarrhea type 1 (DIAR1).	Whole blood (EDTA) or dried blood spot (FTA card)	3–4 weeks from sample receipt (expedited neonatal reports available within 10 days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the SLC26A3 gene", "Copy number variations (deletions/duplications) within the SLC26A3 gene"] Parameters [{"name": "SLC26A3 Gene Sequencing", "reference_range": "No pathogenic variants detected"}, {"name": "Deletion/Duplication Analysis", "reference_range": "No significant copy number variants detected"}] Preparation ["No specific fasting required", "Inform the lab of any relevant family history"] Indications ["Newborn screening for DIAR1", "Diagnosis of suspected DIAR1 based on clinical presentation", "Family screening for carrier status"] Measurement technique Confirm with laboratory Codes LOINC: 81324-1 ICD-10: P78.3 Clinical summary This diagnostic test evaluates the SLC26A3 gene for pathogenic mutations associated with congenital secretory chloride diarrhea type 1 (DIAR1).
TEST-6153 SLC26A6 Gene Hyperoxaluria Genetic Test This test identifies mutations in the SLC26A6 gene associated with primary hyperoxaluria type 2, a metabolic disorder leading to kidney stones.	Peripheral whole blood (EDTA) or buccal swab (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC26A6 gene mutations", "Exons and splice sites of the SLC26A6 gene"] Parameters [] Preparation ["No special fasting or diet is required."] Indications ["Patients with recurrent calcium oxalate kidney stones", "Family screening for hyperoxaluria"] Measurement technique Confirm with laboratory Codes LOINC: 93931-6 ICD-10: E74.81 Clinical summary This test identifies mutations in the SLC26A6 gene associated with primary hyperoxaluria type 2, a metabolic disorder leading to kidney stones.
TEST-4526 SLC2A1 Gene GLUT1 Deficiency Syndrome Type 1 Genetic Test This genetic test analyzes the SLC2A1 gene for mutations associated with Glucose Transporter Type 1 Deficiency Syndrome.	Peripheral whole blood (EDTA) or DNA FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC2A1 gene", "Full gene coverage including intronic and promoter regions"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspicion of GLUT1 deficiency syndrome", "Early-onset epilepsy", "Paroxysmal exercise-induced dyskinesia", "Cognitive delay", "Low CSF glucose responsive to ketogenic therapy"] Measurement technique Confirm with laboratory Codes LOINC: 78041-6 ICD-10: E74.8 Clinical summary This genetic test analyzes the SLC2A1 gene for mutations associated with Glucose Transporter Type 1 Deficiency Syndrome.
TEST-6302 SLC2A5 Gene Fructose Uptake Deficiency Genetic Test This genetic test evaluates the SLC2A5 gene for variants associated with fructose malabsorption.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC2A5 gene", "Fructose transporter (GLUT5) function"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed prior to sample collection"] Indications ["Suspected fructose malabsorption", "Gastrointestinal symptoms triggered by fructose-containing foods", "Differential diagnosis from hereditary fructose intolerance (HFI)"] Measurement technique Confirm with laboratory Codes LOINC: 90995-1 ICD-10: E74.20 Clinical summary This genetic test evaluates the SLC2A5 gene for variants associated with fructose malabsorption.
TEST-4533 SLC35C1 Gene Genetic Test (Leukocyte Adhesion Deficiency Type II / CDG Type IIc) This genetic test evaluates the SLC35C1 gene for pathogenic variants associated with LAD II and CDG Type IIc.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC35C1 gene", "Copy Number Variations (CNV) in SLC35C1"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (via ISO 9001:2015-accredited NGS)"}] Preparation ["Provide detailed medical history and family pedigree during mandatory genetic counseling", "No special dietary or medication changes required unless directed by physician"] Indications ["Suspected Leukocyte Adhesion Deficiency Type II", "Suspected Congenital Disorder of Glycosylation Type IIc", "Family history of LAD II or CDG Type IIc"] Measurement technique Confirm with laboratory Codes LOINC: 81319-1 ICD-10: E77.8 Clinical summary This genetic test evaluates the SLC35C1 gene for pathogenic variants associated with LAD II and CDG Type IIc.
TEST-4545 SLC39A13 Gene Spondylocheirodysplasia, Ehlers-Danlos Syndrome‑like Genetic Test This test detects pathogenic variants in the SLC39A13 gene associated with Spondylocheirodysplasia and Ehlers-Danlos syndrome-like conditions.	Peripheral Whole Blood (EDTA Tube or FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC39A13 gene"] Parameters [] Preparation ["No specific fasting required"] Indications ["Suspected Spondylocheirodysplasia", "Suspected Ehlers-Danlos syndrome-like presentation", "Family history of related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q79.6 Clinical summary This test detects pathogenic variants in the SLC39A13 gene associated with Spondylocheirodysplasia and Ehlers-Danlos syndrome-like conditions.
TEST-5464 SLC45A2 Gene Test This test identifies pathogenic variants in the SLC45A2 gene, which are responsible for Oculocutaneous Albinism Type 4, a rare autosomal recessive disorder affecting melanin produc...	Whole Blood (EDTA), FTA Card, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC45A2 gene", "Point mutations", "Small insertions/deletions", "Copy number variations (CNVs)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}, {"name": "Methodology", "reference_range": "Next Generation Sequencing (NGS)"}, {"name": "Gene Coverage", "reference_range": "Full coding region with CNV detection"}] Preparation ["No fasting required", "Inform collection team if on anticoagulants", "Mandatory pre-test genetic counseling session"] Indications ["Diagnosis of Oculocutaneous Albinism Type 4 (OCA4)", "Carrier screening for individuals with family history", "Family cascade testing"] Measurement technique Confirm with laboratory Codes LOINC: 81226-7 ICD-10: E70.329, E70.3, E70.30, Z15.89 Clinical summary This test identifies pathogenic variants in the SLC45A2 gene, which are responsible for Oculocutaneous Albinism Type 4, a rare autosomal recessive disorder affecting melanin production.
TEST-3592 SLC4A11 Gene Corneal Endothelial Dystrophy Type 2 Genetic Test This genetic test analyzes the SLC4A11 gene to detect mutations associated with corneal endothelial dystrophy type 2.	Whole blood (EDTA), buccal swab, extracted DNA, or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC4A11 gene", "Point mutations", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Share complete clinical history and current medication list"] Indications ["Diagnosis of corneal endothelial dystrophy type 2", "Carrier screening", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H18.59 Clinical summary This genetic test analyzes the SLC4A11 gene to detect mutations associated with corneal endothelial dystrophy type 2.
TEST-3532 SLC4A4 Gene Renal Tubular Acidosis, Proximal, with Ocular Abnormalities Genetic Test This genetic test identifies mutations in the SLC4A4 gene associated with proximal renal tubular acidosis type II and associated ocular abnormalities.	Whole Blood (EDTA), Extracted DNA (≥1 µg), or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SLC4A4 gene coding regions", "SLC4A4 gene splice sites"] Parameters [] Preparation ["Genetic counselling session required prior to sample collection", "Clinical history documentation required"] Indications ["Patients presenting with growth retardation, hyperchloremic metabolic acidosis, and bilateral band keratopathy or glaucoma", "Family cascade screening for SLC4A4-associated pRTA", "Recurrence risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 51963-5 ICD-10: N25.89 Clinical summary This genetic test identifies mutations in the SLC4A4 gene associated with proximal renal tubular acidosis type II and associated ocular abnormalities.
TEST-3492 SLC4A5 Gene (Renal Tubular Acidosis) Test This genetic test identifies pathogenic variants in the SLC4A5 gene, which are associated with proximal renal tubular acidosis with ocular abnormalities.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC4A5 gene", "Single nucleotide variants", "Indels", "Splice-site mutations"] Parameters [] Preparation [] Indications ["Unexplained metabolic acidosis", "Family history of renal tubular disorders", "Failure to thrive", "Nephrocalcinosis"] Measurement technique Confirm with laboratory Codes LOINC: 81245-8 ICD-10: E72.09 Clinical summary This genetic test identifies pathogenic variants in the SLC4A5 gene, which are associated with proximal renal tubular acidosis with ocular abnormalities.
TEST-5791 SLC52A2 Gene Brown‑Vialetto‑Van Laere Syndrome Type 2 Genetic Test This genetic test identifies pathogenic variants in the SLC52A2 gene associated with Brown‑Vialetto‑Van Laere syndrome type 2.	Peripheral Whole Blood (EDTA) or Extracted DNA; also FTA card acceptable.	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SLC52A2 gene", "Full coding region sequencing"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected Brown‑Vialetto‑Van Laere syndrome type 2", "Progressive hearing loss with neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 103527-5 ICD-10: G31.89, G60.0 Clinical summary This genetic test identifies pathogenic variants in the SLC52A2 gene associated with Brown‑Vialetto‑Van Laere syndrome type 2.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.